79th WHA Individual Statements
Agenda item 12.9: Draft updated global action plan on antimicrobial resistance
DNDi welcomes the new Global Action Plan on AMR, including the strategy’s commitment to strengthen research and development, and ensure equitable and sustainable access to new and existing treatments. We look forward to the inception of the Independent Panel for Evidence for Action against AMR, which has the potential to strengthen evidence-based decision-making. AMR should be integrated into global health reform discussions to foster a comprehensive and equitable response that is the joint responsibility of countries, regional institutions, and international organizations.
Finally, we note the importance of continued support for and partnership with international health agencies addressing AMR, including not for profit initiatives such as GARDP, which works to develop and make accessible antibiotic treatments for people in need worldwide.